Andrea Fidler1, Rachel Sweenie1, Adrian Ortega2, Christopher C Cushing2, Rachelle Ramsey3,4, David Fedele1. 1. Department of Clinical & Health Psychology, University of Florida. 2. Clinical Child Psychology Program and Schiefelbusch Institute for Life Span Studies, University of Kansas. 3. Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center. 4. Department of Pediatrics, University of Cincinnati College of Medicine.
Abstract
BACKGROUND: Youth with asthma commonly have suboptimal adherence to inhaled corticosteroids (ICS). It is critical to systematically evaluate the effectiveness of ICS adherence promotion interventions and discern which techniques are most effective. OBJECTIVE: This study aims to (1) quantify the extent to which interventions improve ICS adherence in pediatric asthma, (2) explore differences in effect size estimates based on intervention and study characteristics, and (3) characterize the risk of bias across interventions. METHODS: We conducted literature searches across five databases. Included studies quantitatively measured ICS adherence as an intervention outcome among youth (<18 years old) diagnosed with asthma and were published after 1997. We analyzed aggregate effect sizes and moderator variables using random-effects models and characterized risk of bias using the Cochrane Collaboration tool. RESULTS: Thirty-three unique studies met inclusion criteria. At post-intervention, the aggregate effect size for pediatric ICS adherence promotion interventions was small but significant (n = 33, g = 0.39, 95% confidence interval [CI] = 0.24-0.54); however, the aggregate effect size at follow-up was not statistically significant (n = 6, g = 0.38, 95% CI = -0.08 to 0.83). Method of adherence measurement and intervention format were significant moderators. Most interventions had a high risk of performance bias and an unclear risk of bias in one or more domains. CONCLUSIONS: ICS adherence promotion interventions are effective among youth with asthma. Additional longitudinal research is needed to quantify a more precise measure of intervention effectiveness over time, and moderators of intervention effectiveness should be reassessed as the literature base expands.
BACKGROUND: Youth with asthma commonly have suboptimal adherence to inhaled corticosteroids (ICS). It is critical to systematically evaluate the effectiveness of ICS adherence promotion interventions and discern which techniques are most effective. OBJECTIVE: This study aims to (1) quantify the extent to which interventions improve ICS adherence in pediatric asthma, (2) explore differences in effect size estimates based on intervention and study characteristics, and (3) characterize the risk of bias across interventions. METHODS: We conducted literature searches across five databases. Included studies quantitatively measured ICS adherence as an intervention outcome among youth (<18 years old) diagnosed with asthma and were published after 1997. We analyzed aggregate effect sizes and moderator variables using random-effects models and characterized risk of bias using the Cochrane Collaboration tool. RESULTS: Thirty-three unique studies met inclusion criteria. At post-intervention, the aggregate effect size for pediatric ICS adherence promotion interventions was small but significant (n = 33, g = 0.39, 95% confidence interval [CI] = 0.24-0.54); however, the aggregate effect size at follow-up was not statistically significant (n = 6, g = 0.38, 95% CI = -0.08 to 0.83). Method of adherence measurement and intervention format were significant moderators. Most interventions had a high risk of performance bias and an unclear risk of bias in one or more domains. CONCLUSIONS: ICS adherence promotion interventions are effective among youth with asthma. Additional longitudinal research is needed to quantify a more precise measure of intervention effectiveness over time, and moderators of intervention effectiveness should be reassessed as the literature base expands.
Authors: Marjolein Engelkes; Hettie M Janssens; Johan C de Jongste; Miriam C J M Sturkenboom; Katia M C Verhamme Journal: Eur Respir J Date: 2014-10-16 Impact factor: 16.671
Authors: Francine M Ducharme; Roger L Zemek; Dominic Chalut; David McGillivray; Francisco J D Noya; Sandy Resendes; Lyudmyla Khomenko; Rachel Rouleau; Xun Zhang Journal: Am J Respir Crit Care Med Date: 2010-08-27 Impact factor: 21.405
Authors: Arlene M Butz; Jill Halterman; Melissa Bellin; Joan Kub; Mona Tsoukleris; Kevin D Frick; Richard E Thompson; Cassia Land; Mary E Bollinger Journal: J Asthma Date: 2014-02-27 Impact factor: 2.515
Authors: Michael J Abramson; Rosa L Schattner; Christine Holton; Pam Simpson; Nancy Briggs; Justin Beilby; Mark R Nelson; Richard Wood-Baker; Francis Thien; Nabil D Sulaiman; Eleonora Del Colle; Rory Wolfe; Alan J Crockett; R John Massie Journal: Pediatr Pulmonol Date: 2014-09-08
Authors: Kevin B Johnson; Barron L Patterson; Yun-Xian Ho; Qingxia Chen; Hui Nian; Coda L Davison; Jason Slagle; Shelagh A Mulvaney Journal: J Am Med Inform Assoc Date: 2015-12-11 Impact factor: 4.497
Authors: Rachelle R Ramsey; Jill M Plevinsky; Sophie R Kollin; Robert C Gibler; Theresa W Guilbert; Kevin A Hommel Journal: J Allergy Clin Immunol Pract Date: 2019-12-21